Site Search
Displaying results 141 - 150 of 345
Resource | Guidelines,
The emergence of drug-resistant TB is a major global health concern, which threatens the ambitious goals and progress set under the End TB Strategy. Isoniazid-resistant TB, which is present in 8% of TB cases worldwide, reduces treatment success in patients treated with the standard 6-month first-line regimen.
Resource | Publications,
Tuberculosis (TB) in now the leading infectious killer in the world, having surpassed HIV, and is among the top 10 causes of death worldwide. In 2016, 1.7 million people worldwide died of TB, including 400 000 TB deaths among people living with HIV. The Sustainable Development Goals call for action to end the TB epidemic as a public health threat by 2030, but the pace of progress currently is too slow to achieve this milestone.
Resource | Guidelines,
These new guidelines supersede previous WHO policy documents on the management of Latent TB Infection (LTBI) in people living with HIV, household contacts of people with active TB, other groups at risk of developing TB, and for LTBI testing. The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants.
Resource | Publications,
The 2018 United Nations General Assembly High-Level Meeting (HLM) on Tuberculosis and the current revision of the Roadmap for childhood tuberculosis together present an important moment to consolidate and advance advocacy, commitment, resource mobilization and joint efforts by all stakeholders to provide health care and address the burden of TB among children
Resource | Publications,
Increasing advocacy and efforts to address childhood tuberculosis (TB) at global and country levels have brought the child and adolescent TB epidemic into the spotlight. Building on global strategies, the first Roadmap for childhood tuberculosis: towards zero deaths was developed by WHO and partners, under the guidance of the then Childhood TB Subgroup, and published in October 2013. The 2013 Roadmap laid out the strategic framework for the fight against childhood TB, aiming for zero TB deaths among children, highlighting ten key actions and the enhanced investment needed to address childhood TB.
This document compiles examples of best practices at global, regional and country levels since the launch of the first edition of the Roadmap. It describes 36 examples from 24 countries (including 10 TB, two multidrug-resistant TB (MDR-TB) and four TB/ human immunodeficiency virus (HIV) high burden countries) from all the six WHO regions, two regional initiatives and 12 global initiatives. The examples are categorized according to the ten key actions from the 2013 Roadmap.
Resource | Tools,
Each year we commemorate World TB Day on March 24 to raise public awareness about the devastating health, social and economic impact of tuberculosis (TB) and urge acceleration of efforts to end the global TB epidemic. The aim of this campaign, starting on 19 March, the week of the World TB Day date, is to build overarching commitment and leadership at the highest level to End TB.
Despite significant progress over the last decades, TB continues to be the top infectious killer worldwide, claiming over 4500 lives a day. The emergence of drug-resistant TB (DR-TB) poses a major health threat and could put at risk gains made in efforts to end TB.
Resource | Publications,
2016 was a year in which the world faced many major challenges, including disease outbreaks, humanitarian emergencies, and momentous political shifts. The global health community was challenged to ensure the health of the world’s poorest citizens was not forgotten among the headlines. Our task now is to remind the world that investing in health is not an optional luxury, but an essential element to human and economic development.
Resource | Publications,
TB patients and health-care providers are surrounded by information and communication technologies. They will be using these tools increasingly to obtain better care. However, in doing so they are often faced with basic questions, such as: Which application is best suited to my circumstances? What is the evidence for effectiveness? How do I implement it? Who will pay?
Resource | Publications,
TB is preventable and completely curable–yet about 710 000 people died of TB in 2015. Incomplete treatment can lead to drug-resistant TB over 200 000 people got DR-TB in 2015. Malnutrition, smoking and diabetes aggravate TB. TB thrives in poverty. It also creates poverty; the poor have a five-time higher chance of getting TB.
This is the second SEAR TB Report as we take first steps into the post 2015 era of the SDGs. In 2015, there was an estimated 4.74 million incidence of TB in the SEA Region, including HIV+TB co-infection. The total number of new cases notified to National TB programmes in the Region were around 2.65 million in appear staggering despite a reasonably good performance. Three countries that are poised well to eliminating TB by 2030 are Maldives, Bhutan and Sri Lanka. Nepal too is doing well despite the twin challenges of its mountainous terrain and coping with a major natural disaster. Timor-Leste, though small in terms of absolute TB numbers, faces a major challenge in bringing down its incidence rate.
Resource | Publications,
This report highlights the great achievements that have been made by the Global Fund partnership, supporting programs that have saved more than 22 million lives, while building healthier communities and stronger economies. We have bent the trend lines of tuberculosis and malaria – two of humanity’s ancient foes – and we have prevented AIDS from reaching its catastrophic potential.